Match Document Document Title
US20140309301 ANTIVIRAL TREATMENTS  
The invention provides unit dosage forms, kits, and methods and useful for treating viral infections.
US20120059057 ANTIVIRAL TREATMENTS  
The invention provides unit dosage forms, kits, and methods useful for treating viral infections.
US20110015264 INTRAMUSCULAR ANTIVIRAL TREATMENTS  
The invention provides unit dosage forms, kits, and methods useful for treating viral infections.
US20110038953 STRONTIUM COMPOUND FOR TREATMENT OF SUB-DERMAL SOFT TISSUE PAIN  
The invention provides a method of treatment of a human or non-human subject to combat sub-dermal soft tissue pain therein, said method comprising administering to a subject in need thereof an...
US20150010638 Method for Improving Water Solubility of Slightly Soluble Substance  
It is an object of the present invention to provide a method for improving the solubility of a poorly-soluble substance, which is capable of increasing the solubility of substantially all...
US20120225144 Herbal Supplement Prepared From Geranium  
An extraction method for extracts of Geranium or Pelargonium with improved methylhexaneamine content is provided. The method involves separating the oil phase from the aqueous phase; concentrating...
US20110034551 METHODS OF INCREASING SARCOSINE LEVELS FOR TREATING SCHIZOPHRENIA  
Methods for increasing sarcosine levels in a patient are provided. The methods include activating the PPARα receptor. Increasing sarcosine levels can be used, for example, as part of a treatment...
US20110098303 Method of promoting nail growth using thyromimetic compounds  
The present invention provides methods and compositions for increasing the rate of nail growth in mammals, especially humans, using thyromimetic compounds.
US20120294911 TOPICAL SANITIZER AND METHOD OF USE WITH GLOVES  
Topical sanitizer includes avenanthramides, which is an active component of oats that is beneficial to the skin. The topical sanitizer is used preferably in conjunction with gloves that have an...
US20120277180 Cofactors and Methods for Use for Individuals  
Provided herein are methods and systems for identifying one or more cofactors such as vitamins for individuals based on the genetic makeup of the individual by detecting the presence or absence of...
US20120101074 METHOD AND MEDICATION FOR PREVENTION AND TREATMENT OF OCULAR HYPERTENSION AND GLAUCOMA  
An effective dose of a pharmaceutically acceptable phenylbutyrate salt such as sodium phenylbutyrate applied to human ocular tissues or through injection or other means prevents ocular...
US20110059906 Energy status of an individual by enhanced production of an endogenous fuel source  
The present invention relates to a method of improving the energy status of an individual by enhancing the usage of lactate. Improved lactate usage is accomplished through a composition comprising...
US20120009128 PRESERVATIVE SYSTEM AND COMPOSITION BASED ON GLYCINATE AND HYDROXYETHYL SULFONATE SALT COMBINATION  
A preservative system and a personal care composition containing that system is provided which includes the preservative combination of a C10-C24 acyl glycinate salt and a hydroxyethyl sulfonate...
US20140235604 COMPOUNDS AND METHODS OF TREATING OCULAR DISORDERS  
A method of treating an ocular disorder in a subject associated with aberrant all-trans-retinal clearance in the retina, the method comprising administering to the subject a therapeutically...
US20140329761 PREVENTION AND TREATMENT OF ACUTE INFLAMMATORY CONDITIONS  
The present invention relates generally to methods for the prevention and treatment of acute inflammatory conditions in individuals using an agonist of the complement C3a receptor.
US20060228396 ARGININE-CONTAINING COMPOSITIONS AND METHODS FOR INCREASING BLOOD FLOW USING SAME  
A composition for increasing blood flow is provided, wherein side effects such as lowering of blood pressure are reduced and blood flow is effectively increased in the capillaries. A composition...
US20130184350 Novel NIDDM Regimen  
The present invention relates to the use of a short-acting oral hypoglycemic agent and to a novel regimen in the treatment of type 2 diabetes in which the endogenous secretion of insulin is...
US20130030053 NOVEL NIDDM REGIMEN  
The present invention relates to the use of a short-acting oral hypoglycemic agent and to a novel regimen in the treatment of type 2 diabetes in which the endogenous secretion of insulin is...
US20120202881 Novel NIDDM Regimen  
The present invention relates to the use of a short-acting oral hypoglycemic agent and to a novel regimen in the treatment of type 2 diabetes in which the endogenous secretion of insulin is...
US20110237673 Novel NIDDM Regimen  
The present invention relates to the use of a short-acting oral hypoglycemic agent and to a novel regimen in the treatment of type 2 diabetes in which the endogenous secretion of insulin is...
US20120027723 TAURINE OR TAURINE-LIKE SUBSTANCES FOR THE PREVENTION AND TREATMENT OF A DISEASE ASSOCIATED WITH RETINAL GANGLION CELL DEGENERATION  
The present invention relates to taurine or taurine-like substances for the prevention and treatment of a disease associated with retinal ganglion cell degeneration. More particularly the...
US20150247839 CMPF AS A BIOMARKER FOR DIABETES AND ASSOCIATED METHODS  
Provided are methods for identifying or monitoring a subject having, or at risk of developing, impaired glucose homeostasis. Carboxy-4-methyl-5-propyl-2-furanpropanoic acid (CMPF) is shown to be a...
US20140256817 AMPHIPATHIC AND OTHER DOUBLE-SIDED ALPHA-HELIX MIMETICS BASED ON A 1,2-DIPHENYLACETYLENE SCAFFOLD  
Small-molecule scaffolds based on 1,2-diphenylacetylene that accurately replicate the spatial and angular projections of several side chains on both faces of an α-helix, specifically the i and i+7...
US20140023615 THERMO-SENSITIVE, MUCOADHESIVE OR DERMOADHESIVE, AND PENETRATION-ENHANCING FORMULATIONS FOR TOPICAL DELIVERY OF THERAPEUTICS  
The present invention provides thermo-sensitive, mucoadhesive biopolymer formulations that enhance the penetration of therapeutics across the skin or mucosal surfaces. In a preferred embodiment,...
US20130171209 REDUCING POST-OPERATIVE ADHESION FORMATION WITH INTRAPERITONEAL GLUTAMINE  
Intraperitoneal administration of glutamine to reduce adhesions in the peritoneum of a patient.
US20110028510 Compositions, Methods, and Kits for Treating Influenza Viral Infections  
The present invention provides compositions, methods, and kits for treating or preventing a viral infection (e.g., an infection caused by an influenza virus).
US20150157686 TREATMENTS OF OXIDATIVE STRESS CONDITIONS  
The present invention generally relates to systems and methods for treating certain oxidative stress conditions. In one aspect, compositions and methods of the invention can be used to treat a...
US20120184493 DERMAL FORMULATIONS OF DP2 RECEPTOR ANTAGONISTS  
Described herein are topical formulations for use in the treatment or prevention of dermatological diseases, disorders, or conditions in a mammal. Topical formulations disclosed herein include a...
US20150164837 USE OF AMPHOTERIC SURFACTANTS FOR THE PREVENTION AND TREATMENT OF PATHOGENIC VAGINAL BIOFILMS IN VAGINAL INFECTIONS  
The invention relates to amphotheric surfactants for use in preventing and/or treating vaginal infections, in particular for preventing and treating pathogenic vaginal biofilms in vaginal...
US20130344083 MODULATION OF HISTONE H2B MONOUBIQUITINATION AND TREATMENT OF CANCER  
Provided are methods and compositions for treatment of cancer. In particular, these methods and compositions may include an inhibitor of a deubiquitinating enzyme. In certain aspects, these...
US20110305676 METHODS FOR ENHANCING HEMATOPOIETIC STEM/PROGENITOR CELL ENGRAFTMENT  
Described herein are methods for enhancing engraftment of hematopoietic stem and progenitor cells using compounds identified using a zebrafish model of hematopoietic cell engraftment. The...
US20140187510 MOLECULAR ACTIVATORS OF THE WNT/BETA-CATENIN PATHWAY  
The present invention is directed toward a method of treating a subject for a condition mediated by aberrant Wnt/β-catenin signaling by selecting a subject with a condition mediated by aberrant...
US20150150837 COMPOSITION AND METHOD OF TREATMENT OF NASH  
The present invention relates to a method of treating NASH or NAFLD by delivery of an effective amount of a composition comprising L-glutamine or butyric acid formulated for release in the colon...
US20110092542 METHODS FOR TREATING SPINAL CORD INJURY WITH A COMPOUND THAT INHIBITS A NCCA-ATP CHANNEL  
The present invention is directed to therapeutic compositions targeting the NCCa-ATP channel of an astrocyte, neuron or capillary endothelial cell and methods of using same. More specifically,...
US20140350107 Use of Pan-PPAR Agonists for Prevention and Treatment of Huntington's Disease and Tauopathies  
The present invention provides a therapeutic treatment for a neurodegenerative disease with a pan-PPAR agonist, such as bezafibrate. In particular, the present invention provides that pan-PPAR...
US20150164836 METHODS FOR TREATING NEUTROPENIA USING RETINOID AGONISTS  
The invention provides methods for treating neutropenia in a subject in need thereof comprising providing a composition comprising a retinoid agonist and administering an effective amount of the...
US20140066510 OAT EXTRACTS: REFINING, COMPOSITIONS AND METHODS OF USE  
A simple and efficient method for the production of stable, clear, high-potency oat extracts is disclosed. The method employs the use of differential dissociation constants and ultrafiltration to...
US20110118352 OAT EXTRACTS: REFINING, COMPOSITIONS AND METHODS OF USE  
A simple and efficient method for the production of stable, clear, high-potency oat extracts is disclosed. The method employs the use of differential dissociation constants and ultrafiltration to...
US20100298436 EP2 Agonist from Non-Prostanoid Structures Designed as PGE2 Antagonists  
An EP2-receptor agonist of the following structure is disclosed: which is useful in the treatment of pain, inflammation and lowering intraocular pressure.
US20150258049 X-RAY CONTRAST MEDIA COMPOSITIONS AND METHODS OF USING THE SAME TO TREAT, REDUCE OR DELAY THE ONSET OF CNS INFLAMMATION AND INFLAMMATION ASSOCIATED CONDITIONS  
Embodiments disclosed herein relate to improved X-ray contrast media compositions and methods of using the same for treating symptoms related to allergic reactions, inflammatory conditions,...
US20140079811 X-RAY CONTRAST MEDIA COMPOSITIONS AND METHODS OF USING THE SAME TO TREAT, REDUCE OR DELAY THE ONSET OF CNS INFLAMMATION AND INFLAMMATION ASSOCIATED CONDITIONS  
Embodiments disclosed herein relate to improved X-ray contrast media compositions and methods of using the same for treating symptoms related to allergic reactions, inflammatory conditions,...
US20130071490 X-RAY CONTRAST MEDIA COMPOSITIONS AND METHODS OF USING THE SAME TO TREAT, REDUCE OR DELAY THE ONSET OF CNS INFLAMMATION AND INFLAMMATION ASSOCIATED CONDITIONS  
Embodiments disclosed herein relate to improved X-ray contrast media compositions and methods of using the same for treating symptoms related to allergic reactions, inflammatory conditions,...
US20150209313 USE OF X-RAY CONTRAST MEDIA AND RELATED COMPOSITIONS FOR THE TREATMENT, PREVENTION, REDUCTION OF SEVERITY OF OR DELAY OF THE ONSET OF INFLUENZA  
Embodiments disclosed herein relate to certain compositions including X-ray contrast media compounds and/or certain tri-iodated phenyl compounds and methods of using the same for preventing or...
US20060229256 Enternal administration of arginine and glutamine for abnormal vascular proliferation  
The subject invention provides a method and compositions for preventing and/or treating abnormal vascular proliferation in a human infant where the method involves enterally administering arginine...
US20120010198 Methods for Treating Sleep Disorders by Cholecystokinin (CCK) Receptor B Antagonists  
The present invention relates to a method for preventing or ameliorating a sleep-related breathing disorder. The method involves the use of one or a combination of cholecystokinin (CCK) receptor...
US20100322983 Personal-Care Composition  
A personal-care composition in the form of an oil-in-water emulsion is disclosed that provides improved skin feel and effective wrinkle-filling. The personal-care composition comprises a silicone...
US20140271955 COMPOUNDS AND METHODS FOR INDUCING CHONDROGENESIS  
Described herein are compounds and compositions for the amelioration of arthritis or joint injuries by inducing mesenchymal stem cells into chondrocytes.
US20100056480 USE OF ARGINASE INHIBITORS IN THE TREATMENT OF ASTHMA AND ALLERGIC RHINITIS  
The present invention relates to the use of an arginase inhibitor for the preparation of a medicament for the prophylactic maintenance therapy of an asthmatic or allergic patient by preventing...
US20120108592 PHARMACEUTICAL COMPOSITIONS AND METHODS OF USE OF SALICYLANILIDES FOR TREATMENT OF HEPATITIS VIRUSES  
A new class of salicylanilides is described. These compounds show strong activity against hepatitis viruses.
US20080249063 Composition for promoting the maintenance and function of muscle-specific progenitor cells  
The biological function of skeletal muscle precursor cells in the repair and growth of skeletal muscle in response to exercise is promoted by providing a supplemental composition comprising at...